Aortic atherosclerosis has early been recognized as a potential source
of embolism. The histological finding of cholesterol clefts in small
end-arteries characterized the entity of cholesterol embolism. The cli
nical picture was extremely variable and the diagnosis was frequently
established post-mortem or by means of invasive although insensitive p
rocedures including biopsy and angiography. Therefore, cholesterol emb
olism was thought to be rare. With the routine use of transesophageal
echocardiography for the diagnostic workup of arterial embolism, aorti
c atherosclerosis was shown to be the source of otherwise unexplainabl
e embolism. Cross-sectional studies demonstrated an independent associ
ation between prominent plaques of more than 4 to 5 mm of thickness or
plaques with mobile components in the aortic arch. In follow-up studi
es, the risk of embolic events in patients with this kind of lesions e
xceeded 10 % per patient-year The results of pathological studies were
consistent with these findings showing that ulcerated complex plaques
carry an independent risk for embolic events. Apart from spontaneous
embolism, atherosclerosis of the proximal aorta was shown to be a caus
e of embolic complications during cardiac surgery and catheterization
procedures which involve the aorta. Medical treatment for the preventi
on of embolism in atherosclerotic disease of the aorta has not been st
udied systematically. In a variant form of aortic atherosclerosis cons
isting of mobile pedunculated thrombi inserting on relatively small pl
aques, anticoagulant therapy has proved to be useful in small numbers
of patients. Recurrent embolic events could be prevented and regressio
n of the thrombotic masses has been observed.